(See Solution) Pifzer and BioNTech announced the results of Phase III trials of their experimental COVID-19 vaccine in November 2020. 43,000 participants


Question: Pifzer and BioNTech announced the results of Phase III trials of their experimental COVID-19 vaccine in November 2020. 43,000 participants were randomly divided into two equal groups, with half given a placebo and half given a vaccine. 162 of the participants in the placebo group became sick, and 8 participants in the treatment group. How confident can we be that the vaccine is effective (i.e., that it reduces sickness relative to the placebo group)? Data to answer this question is in covid vaccine.csv.

Price: $2.99
Solution: The downloadable solution consists of 3 pages
Deliverable: Word Document

log in to your account

Don't have a membership account?
REGISTER

reset password

Back to
log in

sign up

Back to
log in